Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.5000
0.00 (0.00%)
Apr 14, 2026, 9:54 AM EST
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $20.39 million as of April 15, 2026. Its market cap has decreased by -63.50% in one year.
Market Cap
20.39M
Enterprise Value
11.35M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.50
Market Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 20.39M, a decrease of -87.66%. That is a compound annual growth rate of -34.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 20.39M | -50.86% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | 165.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harvard Apparatus Regenerative Technology | 27.64M |
| Arch Biopartners | 24.30M |
| Provectus Biopharmaceuticals | 23.07M |
| Oncotelic Therapeutics | 16.04M |
| Zeo ScientifiX | 15.55M |
| EOM Pharmaceuticals Holdings | 15.03M |
| HOOKIPA Pharma | 14.66M |
| Inhibitor Therapeutics | 13.81M |